These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5386703)

  • 21. A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device.
    Sussman NL; Finegold MJ; Barish JP; Kelly JH
    Am J Gastroenterol; 1994 Jul; 89(7):1077-82. PubMed ID: 7517100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B].
    Chen YP; Zhu YF; Feng XR; Peng J; Hou JL
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research on hepatic blood flow in chronic hepatitis].
    Banciu T
    Med Interna (Bucur); 1969 Apr; 21(4):467-72. PubMed ID: 5803850
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatoprotective effect of prostaglandins].
    Vengerovskiĭ AI; Baturina NO; Saratikov AS
    Eksp Klin Farmakol; 1997; 60(5):78-82. PubMed ID: 9483413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
    Ginsberg HN
    Cell Metab; 2006 Sep; 4(3):179-81. PubMed ID: 16950134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of glucocorticoid therapy on protein synthesis in liver punctates in patients with acute hepatitis].
    Richter E; Rotter S; Leinweber B; Liehr H; Brachtel D; Kühn HA
    Acta Hepatosplenol; 1970; 17(2):84-9. PubMed ID: 5524293
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interconnection in activity of lipid peroxidation reactions and functional status of the liver in patients with chronic hepatitis of viral etiology].
    Tkachev VD; Nilova TV; Shustova SG; Petrakov AV; Sil'vestrova SIu; Drozdov VN
    Eksp Klin Gastroenterol; 2002; (6):35-7, 112. PubMed ID: 12685009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneoscopy in chronic hepatitis. A retrospective evaluation of its role in the management of the asymptomatic patient.
    Mazzacca G; Bianco AR; Vecchione R; Piai G; Capalbo G; Budillon G
    Am J Gastroenterol; 1980 Sep; 74(3):244-50. PubMed ID: 6451170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of patients with chronic hepatitis using ursodeoxycholic acid.
    Nambu M; Iijima T
    Trop Gastroenterol; 1993; 14(2):59-65. PubMed ID: 8291125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response.
    Imai Y; Kasahara A; Tanaka H; Okanoue T; Hiramatsu N; Tsubouchi H; Yoshioka K; Kawata S; Tanaka E; Hino K; Hayashi K; Tamura S; Itoh Y; Sasaki Y; Kiyosawa K; Kakumu S; Okita K; Hayashi N
    J Gastroenterol; 2004 Nov; 39(11):1069-77. PubMed ID: 15580400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anemic syndrome in chronic hepatitis and liver cirrhosis].
    Korolko IuR; Sarycheva TG; Kotelńikov VM; Kozinets GI; Zherebtsov LA
    Klin Med (Mosk); 1993; 71(5):45-8. PubMed ID: 8301986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver derived endogenous opioids may interfere with the therapeutic effect of interferon in chronic hepatitis C.
    Bergasa NV; Boyella VD
    Med Hypotheses; 2008; 70(3):556-9. PubMed ID: 17692472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacometabolic capacity of the liver and the effect of pancreozymin in chronic hepatitis, chronic pancreatitis and diabetes mellitus].
    Geller LI; Griaznova MV; Bulgakova OS; Kozlova ZP
    Ter Arkh; 1982; 54(2):67-9. PubMed ID: 7071776
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of liver biopsy and serochemical studies in the clinical course control of chronic hepatitis].
    Theuer D
    Z Gesamte Inn Med; 1968 Jun; 23(11):Suppl:171-4. PubMed ID: 5706972
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of the functional status of the liver on certain hematologic indices (based on data of remote observations of patients recovered from infectious hepatitis)].
    Geller LI; Kozlova ZP
    Klin Med (Mosk); 1968 May; 46(5):58-61. PubMed ID: 5669588
    [No Abstract]   [Full Text] [Related]  

  • 39. [Correlation of biochemical and histopathological findings in acute viral hepatitis].
    Valdivia Carpio H; Figueroa R
    An Fac Med Lima; 1967; 50(1):90-104. PubMed ID: 5596969
    [No Abstract]   [Full Text] [Related]  

  • 40. [Morphological liver changes of chronic hepatitis C in antiretroviral-naive HIV-infected patients].
    Grabczewska E; Pawłowska M
    Przegl Epidemiol; 2005; 59(2):423-30. PubMed ID: 16190550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.